Literature DB >> 15853561

Sumatriptan: a decade of use and experience in the treatment of migraine.

Fred D Sheftell1, Marcelo E Bigal, Stewart J Tepper, Alan M Rapoport.   

Abstract

The migraine-specific triptans have revolutionized the treatment of migraine and are usually the drugs of choice to treat a migraine attack in progress. Sumatriptan (Imitrex) has been available for the longest time within the class, is most flexible in form and has been given successfully to the most number of patients. It is useful for the full range of attacks experienced by a migraine suffer. The aim of this review is to provide an overview of the first 10 years of the use of sumatriptan.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15853561     DOI： 10.1586/14737175.4.2.199

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN： 1473-7175            Impact factor:   4.618


  6 in total

1.  Effect of sumatriptan on gastric emptying: a crossover study using the BreathID system.

Authors:  Yasunari Sakamoto; Yusuke Sekino; Eiji Yamada; Takuma Higurashi; Hidenori Ohkubo; Eiji Sakai; Hiroki Endo; Hiroshi Iida; Takashi Nonaka; Koji Fujita; Masato Yoneda; Tomoko Koide; Hirokazu Takahashi; Ayumu Goto; Yasunobu Abe; Eiji Gotoh; Shin Maeda; Atsushi Nakajima; Masahiko Inamori
Journal:  World J Gastroenterol       Date:  2012-07-14       Impact factor: 5.742

Review 2.  Marine indole alkaloids: potential new drug leads for the control of depression and anxiety.

Authors:  Anna J Kochanowska-Karamyan; Mark T Hamann
Journal:  Chem Rev       Date:  2010-08-11       Impact factor: 60.622

3.  Electrophilic Carbonyl Activation: Competing Condensative Cyclizations of Tryptamine Derivatives.

Authors:  Fan Liu; Mohammad Movassaghi
Journal:  Tetrahedron Lett       Date:  2015-06-03       Impact factor: 2.415

Review 4.  Intranasal medications for the treatment of migraine and cluster headache.

Authors:  Alan M Rapoport; Marcelo E Bigal; Stewart J Tepper; Fred D Sheftell
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

5.  Reversal of inflammatory and noninflammatory visceral pain by central or peripheral actions of sumatriptan.

Authors:  Louis P Vera-Portocarrero; Michael H Ossipov; Tamara King; Frank Porreca
Journal:  Gastroenterology       Date:  2008-07-03       Impact factor: 22.682

6.  Treatment satisfaction and efficacy of the rapid release formulation of sumatriptan 100 mg tablets utilising an early intervention paradigm in patients previously unsatisfied with sumatriptan.

Authors:  L C Newman; R K Cady; S Landy; P O'Carroll; W J Kwong; S P Burch; A C Nelsen; S A McDonald
Journal:  Int J Clin Pract       Date:  2008-12       Impact factor: 2.503
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.